2Suppliers
4Customers
3Debt Items
0Related Chains

Source-Backed Evidence Depth

Regencell Bioscience Holdings Limited (RGC) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

10Total relationships
3Distinct source URLs
6High confidence
0.790Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Regencell Bioscience Holdings Limited Suppliers

TickerNameConfidenceEvidence
TCM-PRACTITIONER TCM-PRACTITIONER 92% Pursuant to the Strategic Partnership Agreement we have with TCM Practitioner, we have exclusive rights and ownership of (1) all his TCM formula and (2) the intellectual property rights of the TCM fo…
HONOR-EPIC-ENTERPRISES-LIMITED HONOR-EPIC-ENTERPRISES-LIMITED 90% On September 2, 2021, our wholly-owned subsidiary, Regencell Bioscience Limited entered into a joint venture agreement with Honor Epic Enterprises Limited to form a joint venture, Regencell Bioscienc…

Regencell Bioscience Holdings Limited Customers

TickerNameConfidenceEvidence
ACE-UNITED-INTERNATIONAL-LIMITED ACE-UNITED-INTERNATIONAL-LIMITED 62% skillfully apply TCM fundamental principles of compatibility to ensure the roles of each individual herb do not counteract with each other or become collectively harmful. The resulting combination cr…
HOLDING-COMPANY-STRUCTURE-REGENCELL-BIOSCIENCE-H HOLDING-COMPANY-STRUCTURE-REGENCELL-BIOSCIENCE-H 62% lion and $6.1 million for the years ended June 30, 2024 and 2023, respectively. 59 Results of Operations for the Years Ended June 30, 2023 and 2022 The following table sets forth our results of opera…
HONG-KONG-REGENCELL-LIMITED HONG-KONG-REGENCELL-LIMITED 62% lion and $6.1 million for the years ended June 30, 2024 and 2023, respectively. 59 Results of Operations for the Years Ended June 30, 2023 and 2022 The following table sets forth our results of opera…
NASDAQ-STOCK-MARKET-LLC NASDAQ-STOCK-MARKET-LLC 62% affairs including, but not limited to, the judiciary and courts of last resort, immigration and customs, public finance, currencies and extradition. Hong Kong continues using the English common law s…

Regencell Bioscience Holdings Limited Debt Obligations

InstrumentDescriptionConfidenceEvidence
RGC-DEBT-12154 Warrants outstanding: 301085 90% xbrl warrant detail from xbrl 2022-06-30.
RGC-DEBT Debt stack $3.0M 90% Market cache reports total debt of $3.0M.
RGC-DEBT-12155 Xbrl Convertible 90% xbrl convertible detail from xbrl 2022-06-30.

Regencell Bioscience Holdings Limited Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Regencell Bioscience Holdings Limited.

Regencell Bioscience Holdings Limited Ownership

HolderNameConfidenceEvidence
RGC-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC GEODE CAPITAL MANAGEMENT, LLC 90% 13F overlay lists GEODE CAPITAL MANAGEMENT, LLC as top holder; 35 tracked holders.

Regencell Bioscience Holdings Limited Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.
🔐
RGC
Unlock RGC Supply Chain Data
Verified relationships include:
TCM-PRACTITIONERTCM-PRACTITIONERSupplier92%
HONOR-EPIC-ENTERPRISES-LIMITEDHONOR-EPIC-ENTERPRISES-LIMITEDSupplier90%
ACE-UNITED-INTERNATIONAL-LIMITEDACE-UNITED-INTERNATIONAL-…Customer62%
HOLDING-COMPANY-STRUCTURE-REGENCELL-BIOSCIENCE-HHOLDING-COMPANY-STRUCTURE…Customer62%
+6 more relationships locked
Subscribe, View plans →